At a glance
ClinicalIndex Comparison RecordN/ACompleted· 13 enrolled
Drug / intervention
Proton radiation and chemotherapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study Using Photon/Proton Beam Radiation Therapy and Chemotherapy for Unresectable Carcinoma of the Pancreas
In Brief
A clinical study evaluating Proton radiation and chemotherapy for Pancreatic Cancer. Completed, enrolled 13 participants across 1 site.
Detailed Summary
The purpose of this study is to find out what effects, good and/or bad, proton radiation and chemotherapy has on you and your pancreatic cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedMay 2008
Primary CompletionOct 2013
Study CompletionJun 2017
TodayJul 2026
First PostedMay 28, 2008
Enrollment StartMar 1, 2008
Primary CompletionOct 1, 2013
Study CompletionJun 29, 2017
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 18.1 years ago
Interventions
Proton radiation and chemotherapyradiation
Proton radiation 59.4 CGE in 33 fx at 1.8 CGE per fx over 7 weeks . Chemotherapy: Capecitabine (Xeloda ®) 1,000 mg by mouth twice a day, 5 days/week (M-F) Consolidation Chemotherapy: Suggested Regimen - Gemcitabine total of 12 doses